Latest News

Horizon Therapeutics plc Announces Changes in Research and Development Organization

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and external search; Srini Ramanathan, Ph.D., group vice president, development sciences and San Francisco site head and Melanie Gloria, senior vice president, R&D operations, will report to Timothy Walbert, chairman, president and chief executive offi

Source link

Related posts

Aspen Dental Makes Access to Comprehensive Care Easier in Twin Falls, ID


Animal-assisted therapy has a positive effect on social behavior of patients with brain injuries


PredictImmune Announces New Patent Grants and Allowances Across the UK, EU and Canada


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy